Following the receipt of updated shares in issue information from Nemesis Constructions (Cyprus, constituent), FTSE announces the following changes: | INDEX | CHANGE | EFFECTIVE FROM
START OF TRADING | | FTSE Med 100 Index | Nemesis Constructions (Cyprus, 4229641) will remain in the index with an increased shares in issue total of 61,055,718 and a unchanged investability weighting of 40%.
| 07 November 2011 |
For index related enquiries or further information about FTSE please contact: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | Tel: +1 888 747 FTSE (3873) or +1 212 314 1139 | | Client Services in Asia Pacific: | Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 |
Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com |
